Related references
Note: Only part of the references are listed.Vascular co-option in brain metastasis
Pedro Garcia-Gomez et al.
ANGIOGENESIS (2020)
The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas
Ricardo Gargini et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
SOX9 promotes tumor progression through the axis BMI1-p21CIP
Paula Aldaz et al.
SCIENTIFIC REPORTS (2020)
Cell Lineage-Based Stratification for Glioblastoma
Zilai Wang et al.
CANCER CELL (2020)
Immune Profiling of Gliomas Reveals a Connection with IDH1/2 Mutations, Tau Function and the Vascular Phenotype
Teresa Cejalvo et al.
CANCERS (2020)
The blood-brain barrier and blood-tumour barrier in brain tumours and metastases
Costas D. Arvanitis et al.
NATURE REVIEWS CANCER (2020)
Role and Molecular Mechanisms of Pericytes in Regulation of Leukocyte Diapedesis in Inflamed Tissues
Paulina Rudziak et al.
MEDIATORS OF INFLAMMATION (2019)
SOX9 Stem-Cell Factor: Clinical and Functional Relevance in Cancer
Maribel Aguilar-Medina et al.
JOURNAL OF ONCOLOGY (2019)
VEGF as a modulator of the innate immune response in glioblastoma
Kati Turkowski et al.
GLIA (2018)
Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome
Daniel A. P. Guerra et al.
ANGIOGENESIS (2018)
A Glial Signature and Wnt7 Signaling Regulate Glioma-Vascular Interactions and Tumor Microenvironment
Amelie Griveau et al.
CANCER CELL (2018)
Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules
Bo He et al.
JOURNAL OF PATHOLOGY (2018)
Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization
Ekrem Emrah Er et al.
NATURE CELL BIOLOGY (2018)
In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature
Named Akbari et al.
NEURO-ONCOLOGY (2018)
IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas
Lei Zhang et al.
NEURO-ONCOLOGY (2018)
Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma
Andreas Stadlbauer et al.
NEURO-ONCOLOGY (2018)
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance
Yu Shi et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours
Adama Sidibe et al.
NATURE COMMUNICATIONS (2018)
hiPSC-derived neural stem cells from patients with schizophrenia induce an impaired angiogenesis
Barbara S. Casas et al.
TRANSLATIONAL PSYCHIATRY (2018)
A molecular atlas of cell types and zonation in the brain vasculature
Michael Vanlandewijck et al.
NATURE (2018)
Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy
Jin-Ku Lee et al.
NATURE GENETICS (2018)
Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses
Siobhan Conroy et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
EGFR and EGFRvIII Promote Angiogenesis and Cell Invasion in Glioblastoma: Combination Therapies for an Effective Treatment
Stefanie Keller et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
Xun Jin et al.
NATURE MEDICINE (2017)
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade
Martina Schmittnaegel et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Targeting Glioma Stem Cell-Derived Pericytes Disrupts the Blood-Tumor Barrier and Improves Chemotherapeutic Efficacy
Wenchao Zhou et al.
CELL STEM CELL (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
T1-Weighted Dynamic Contrast-Enhanced MRI Is a Noninvasive Marker of Epidermal Growth Factor Receptor vIII Status in Cancer Stem Cell–Derived Experimental Glioblastomas
L.S. Politi et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2016)
Normalization of Tumor Vessels by Tie2 Activation and Ang2 Inhibition Enhances Drug Delivery and Produces a Favorable Tumor Microenvironment
Jin-Sung Park et al.
CANCER CELL (2016)
mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance
Laura Garros-Regulez et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2016)
Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells
Anitha K. Shenoy et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation
Eskil Eskilsson et al.
NEURO-ONCOLOGY (2016)
Ang-2/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival
Jonas Kloepper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Immune Regulation by Pericytes: Modulating Innate and Adaptive Immunity
Rocio Navarro et al.
FRONTIERS IN IMMUNOLOGY (2016)
T1-Weighted Dynamic Contrast-Enhanced MRI as a Noninvasive Biomarker of Epidermal Growth Factor Receptor vIII Status
J. Arevalo-Perez et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2015)
Preclinical Test of Dacomitinib, an Irreversible EGFR Inhibitor, Confirms Its Effectiveness for Glioblastoma
Cristina Zahonero et al.
MOLECULAR CANCER THERAPEUTICS (2015)
EGFR Mutation Promotes Glioblastoma through Epigenome and Transcription Factor Network Remodeling
Feng Liu et al.
MOLECULAR CELL (2015)
Notch1 Stimulation Induces a Vascularization Switch With Pericyte-Like Cell Differentiation of Glioblastoma Stem Cells
Pierre-Olivier Guichet et al.
STEM CELLS (2015)
Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration
Sandra S. Edwards et al.
ANGIOGENESIS (2014)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy
Cristina Zahonero et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Selective Antitumor Activity of Ibrutinib in EGFR-Mutant Non-Small Cell Lung Cancer Cells
Wen Gao et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Vessel calibre-a potential MRI biomarker of tumour response in clinical trials
Kyrre E. Emblem et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma
Lijoy K. Mathew et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Glioblastoma Stem Cells Generate Vascular Pericytes to Support Vessel Function and Tumor Growth
Lin Cheng et al.
CELL (2013)
The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors
An Wouters et al.
CURRENT PHARMACEUTICAL DESIGN (2013)
Continuous daily sunitinib for recurrent glioblastoma
Teri Nguyen Kreisl et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma
Yasufumi Katanasaka et al.
MOLECULAR CANCER (2013)
Mechanisms of Glioma-Associated Neovascularization
Matthew E. Hardee et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Oncogenic role of SOX9 expression in human malignant glioma
Liang Wang et al.
MEDICAL ONCOLOGY (2012)
PDGFRβ Signaling Regulates Mural Cell Plasticity and Inhibits Fat Development
Lorin E. Olson et al.
DEVELOPMENTAL CELL (2011)
Evidence for Sequenced Molecular Evolution of IDH1 Mutant Glioblastoma From a Distinct Cell of Origin
Albert Lai et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
HIF1α induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion
Rose Du et al.
CANCER CELL (2008)
Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor α expression
Markus Finzsch et al.
DEVELOPMENT (2008)
Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma
Nicole Simonavicius et al.
MODERN PATHOLOGY (2008)
Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways
Jerome E. Lafont et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer
Aleksandra Franovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A combined ex/in vivo assay to detect effects of exogenously added factors in neural stem cells
Sacri R. Ferron et al.
NATURE PROTOCOLS (2007)
Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis
HS Phillips et al.
CANCER CELL (2006)
Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer
Daniel Edmund Bryan Swinson et al.
CLINICAL LUNG CANCER (2006)
Tie2 identifies a hematopoietic monocytes required for tumor lineage of proangiogenic vessel formation and a mesenchymal population of pericyte progenitors
M De Palma et al.
CANCER CELL (2005)
Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors
A Abramsson et al.
JOURNAL OF CLINICAL INVESTIGATION (2003)
Share Paper
